Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting | Business Wire

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting | Business Wire: Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that seven abstracts highlighting progress in the Rubraca preclinical research and clinical devel